Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study.

Louw, Elizabeth Helene; Chothia, Mogamat-Yazied

Louw, Elizabeth Helene; Chothia, Mogamat-Yazied.

Afiliación

Louw EH; Divisions of General Medicine and Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, 7505, South Africa.
Chothia MY; Divisions of General Medicine and Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, 7505, South Africa. yaziedc@sun.ac.za.

BMC Nephrol ; 18(1): 336, 2017 Nov 25.

Article en En | MEDLINE | ID: mdl-29178879

Asunto(s)

Eritropoyetina/sangre; Eritropoyetina/orina; Fallo Renal Crónico/sangre; Fallo Renal Crónico/orina; Pruebas de Función Renal/tendencias; Diálisis Renal/tendencias; Adulto; Estudios Transversales; Relación Dosis-Respuesta a Droga; Femenino; Humanos; Fallo Renal Crónico/terapia; Masculino; Persona de Mediana Edad

Palabras clave

Chronic dialysis; Erythropoietin resistance index; Erythropoietin stimulating agent dose requirements; Residual renal function

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Eritropoyetina / Diálisis Renal / Fallo Renal Crónico / Pruebas de Función Renal Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: BMC Nephrol Asunto de la revista: NEFROLOGIA Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google